What is Zacks Research’s Estimate for CLB Q2 Earnings?

Core Laboratories Inc. (NYSE:CLB) – Equities researchers at Zacks Research issued their Q2 2026 earnings per share estimates for shares of Core Laboratories in a report released on Tuesday, May 19th. Zacks Research analyst Team forecasts that the oil and gas company will post earnings of $0.07 per share for the quarter. The consensus estimate for Core Laboratories’ current full-year earnings is $0.54 per share. Zacks Research also issued estimates for Core Laboratories’ Q3 2026 earnings at $0.18 EPS, Q4 2026 earnings at $0.27 EPS, FY2026 earnings at $0.57 EPS, Q1 2027 earnings at $0.10 EPS, Q2 2027 earnings at $0.28 EPS, Q3 2027 earnings at $0.21 EPS, Q4 2027 earnings at $0.24 EPS, FY2027 earnings at $0.83 EPS, Q1 2028 earnings at $0.23 EPS and FY2028 earnings at $1.10 EPS.

Several other equities research analysts also recently commented on the company. Wall Street Zen upgraded Core Laboratories from a “sell” rating to a “hold” rating in a report on Sunday. Weiss Ratings lowered shares of Core Laboratories from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 4th. Three analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Core Laboratories has a consensus rating of “Hold” and a consensus price target of $12.00.

Core Laboratories Stock Up 0.0%

Shares of Core Laboratories stock opened at $13.72 on Thursday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.50 and a current ratio of 2.05. The stock has a market capitalization of $632.54 million, a PE ratio of 21.11, a price-to-earnings-growth ratio of 2.72 and a beta of 0.99. Core Laboratories has a 52-week low of $9.72 and a 52-week high of $20.36. The company has a 50-day simple moving average of $15.78 and a two-hundred day simple moving average of $16.70.

Core Laboratories (NYSE:CLB) last announced its quarterly earnings results on Wednesday, April 29th. The oil and gas company reported $0.06 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.06. Core Laboratories had a net margin of 5.94% and a return on equity of 11.52%. The company had revenue of $121.80 million for the quarter, compared to analysts’ expectations of $122.99 million. During the same quarter in the previous year, the business posted $0.14 EPS. Core Laboratories’s revenue was down 1.4% compared to the same quarter last year. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of CLB. CWM LLC grew its stake in shares of Core Laboratories by 36.1% during the 4th quarter. CWM LLC now owns 2,516 shares of the oil and gas company’s stock valued at $40,000 after purchasing an additional 668 shares during the period. Platinum Investment Management Ltd. lifted its stake in shares of Core Laboratories by 3.9% in the 3rd quarter. Platinum Investment Management Ltd. now owns 23,758 shares of the oil and gas company’s stock worth $294,000 after purchasing an additional 889 shares during the period. Illinois Municipal Retirement Fund boosted its holdings in shares of Core Laboratories by 4.0% in the third quarter. Illinois Municipal Retirement Fund now owns 23,366 shares of the oil and gas company’s stock worth $289,000 after buying an additional 898 shares during the last quarter. Advisors Capital Management LLC grew its position in Core Laboratories by 0.3% during the third quarter. Advisors Capital Management LLC now owns 275,975 shares of the oil and gas company’s stock valued at $3,411,000 after buying an additional 912 shares during the period. Finally, Fox Run Management L.L.C. increased its holdings in Core Laboratories by 5.9% during the third quarter. Fox Run Management L.L.C. now owns 18,531 shares of the oil and gas company’s stock valued at $229,000 after buying an additional 1,038 shares during the last quarter. Institutional investors own 97.81% of the company’s stock.

Core Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 1st. Investors of record on Monday, May 11th will be issued a $0.01 dividend. The ex-dividend date of this dividend is Monday, May 11th. This represents a $0.04 annualized dividend and a dividend yield of 0.3%. Core Laboratories’s payout ratio is presently 6.15%.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.